Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eloisa Jantus Lewintre

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Journal of Clinical Medicine|April 30, 2021
Potential Non-Invasive Biomarkers for Early Diagnosis of Oral Squamous Cell CarcinomaValentina Dikova, Eloisa Jantus-Lewintre, Jose Bagan
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Update on biomarkers for the detection of lung cancerEloisa Jantus-Lewintre, Marta Usó, Elena Sanmartín, et al.
Biomed Research International|September 9, 2014
MicroRNAs: promising new antiangiogenic targets in cancerSandra Gallach, Silvia Calabuig-Fariñas, Eloisa Jantus-Lewintre, et al.
Future Oncology (London, England)|December 5, 2014
miRNA detection methods and clinical implications in lung cancerMarta Usó, Eloisa Jantus-Lewintre, Rafael Sirera, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 1, 2006
Bortezomib induces different apoptotic rates in B-CLL cells according to IgVH and BCL-6 mutationsEloisa Jantus-Lewintre, Elena Sarsotti, María José Terol, et al.
Critical Reviews in Oncology/Hematology|January 17, 2025
Role of the International Society of Liquid Biopsy (ISLB) in establishing quality control frameworks for clinical integrationNicola Fusco, Eloisa Jantus-Lewintre, Maria Jose Serrano, et al.
Critical Reviews in Oncology/Hematology|August 4, 2023
Advancements in synthetic biology-based bacterial cancer therapy: A modular design approachAndrés Arboleda-García, Ivan Alarcon-Ruiz, Lissette Boada-Acosta, et al.
Cancer Biology & Medicine|June 29, 2023
Biological insights in non-small cell lung cancerRafael Rosell, Anisha Jain, Jordi Codony-Servat, et al.
Clinical Lung Cancer|July 7, 2011
Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patientsEloisa Jantus-Lewintre, Rafael Sirera, Andrea Cabrera, et al.
Lung Cancer (Amsterdam, Netherlands)|April 13, 2011
Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLCEloisa Jantus-Lewintre, Elena Sanmartín, Rafael Sirera, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Journal of Clinical Medicine|April 30, 2021
Potential Non-Invasive Biomarkers for Early Diagnosis of Oral Squamous Cell CarcinomaValentina Dikova, Eloisa Jantus-Lewintre, Jose Bagan
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Update on biomarkers for the detection of lung cancerEloisa Jantus-Lewintre, Marta Usó, Elena Sanmartín, et al.
Biomed Research International|September 9, 2014
MicroRNAs: promising new antiangiogenic targets in cancerSandra Gallach, Silvia Calabuig-Fariñas, Eloisa Jantus-Lewintre, et al.
Future Oncology (London, England)|December 5, 2014
miRNA detection methods and clinical implications in lung cancerMarta Usó, Eloisa Jantus-Lewintre, Rafael Sirera, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 1, 2006
Bortezomib induces different apoptotic rates in B-CLL cells according to IgVH and BCL-6 mutationsEloisa Jantus-Lewintre, Elena Sarsotti, María José Terol, et al.
Critical Reviews in Oncology/Hematology|January 17, 2025
Role of the International Society of Liquid Biopsy (ISLB) in establishing quality control frameworks for clinical integrationNicola Fusco, Eloisa Jantus-Lewintre, Maria Jose Serrano, et al.
Critical Reviews in Oncology/Hematology|August 4, 2023
Advancements in synthetic biology-based bacterial cancer therapy: A modular design approachAndrés Arboleda-García, Ivan Alarcon-Ruiz, Lissette Boada-Acosta, et al.
Cancer Biology & Medicine|June 29, 2023
Biological insights in non-small cell lung cancerRafael Rosell, Anisha Jain, Jordi Codony-Servat, et al.
Clinical Lung Cancer|July 7, 2011
Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patientsEloisa Jantus-Lewintre, Rafael Sirera, Andrea Cabrera, et al.
Lung Cancer (Amsterdam, Netherlands)|April 13, 2011
Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLCEloisa Jantus-Lewintre, Elena Sanmartín, Rafael Sirera, et al.
Pageof 7